Innovex International Inc美股招股说明书(2026-08-06版)

Innovex International, Inc. Common Stock The selling stockholders identified in this prospectus supplement (the “selling stockholders”) are offering 5,000,000 shares ofcommon stock, par value $0.01 per share (“common stock”), of Innovex International, Inc. (the “Company,” “we,” “us” and “our”).We will not receive any proceeds from the sale of shares by the selling stockholders. The underwriter has agreed to purchase shares of common stock from the selling stockholders at a price of $per share, whichwill result in $of proceeds to the selling stockholders before expenses. The underwriter may offer shares of common stock fromtime to time for sale in one or more transactions on the NYSE, in the over-the-counter market, through negotiated transactions orotherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. See“Underwriting” for a description of the compensation payable to the underwriter. The common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “INVX”. The last sale price ofthe common stock as reported by the NYSE on August4, 2026 was $31.63per share. Investing in the common stock involves risks, including those described in the “Risk Factors” sectionbeginning on page S-3 of this prospectus supplement, on page1 of the accompanying prospectus and inthe documents incorporated by reference in this prospectus supplement and the accompanyingprospectus. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved ordisapproved of these securities or passed upon the accuracy or adequacy of the disclosures in the prospectus. Anyrepresentation to the contrary is a criminal offense. Barclays Table of Contents Table of ContentsProspectus Supplement ABOUT THIS PROSPECTUS SUPPLEMENTWHERE YOU CAN FIND MORE INFORMATIONCAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTSSUMMARYRISK FACTORSUSE OF PROCEEDSDIVIDEND POLICYSELLING STOCKHOLDERSMATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERSCERTAIN ERISA CONSIDERATIONSUNDERWRITINGLEGAL MATTERSEXPERTS Prospectus ABOUT THIS PROSPECTUSWHERE YOU CAN FIND MORE INFORMATION CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTSINNOVEX INTERNATIONAL, INC.RISK FACTORSUSE OF PROCEEDSSELLING STOCKHOLDERSDESCRIPTION OF CAPITAL STOCK PLAN OF DISTRIBUTION Table of Contents ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and supplements andupdates the information contained in the accompanying prospectus. The second part is the accompanying prospectus, which provides more generalinformation, some of which may not apply to this offering. Generally, when we use the term “prospectus,” we are referring to both parts combined. Youshould read this entire prospectus supplement as well as the accompanying prospectus and the documents incorporated by reference that are describedunder the “Where You Can Find More Information” section in this prospectus supplement. To the extent that any statement in this prospectussupplement is inconsistent with statements made in the accompanying prospectus, you should rely on the information contained in this prospectussupplement, which will be deemed to modify or supersede those made in the accompanying prospectus. In making an investment decision, prospective investors must rely on their own examination of us and the terms of this offering, including themerits and risks involved. Neither we, the selling stockholders, the underwriter nor any of our or their respective representatives are making anyrepresentation to you regarding the legality of an investment in our common stock by you under applicable laws. You should consult with your ownadvisors as to legal, tax, business, financial and related aspects of an investment in our common stock. Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will bedeemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or in any othersubsequently filed document that is also incorporated by reference into this prospectus modifies or supersedes that statement. Any statement so modifiedor superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. Please read “Where You Can Find MoreInformation” in this prospectus supplement. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus and any free writing prospectus isaccurate only as of the date on its respective cover, regardless of the time of delivery of this prospectus supplement or any sale of our common stock,and that any information incorporated by reference herein or therein is accurate only as of the date of the document incorp